U.S., Feb. 4 -- An application to own the trademark for 'DAXCERB' has been filed on Aug. 26, 2025.
Owner(s):
Pfizer Inc.; 66 Hudson Boulevard East, , NEW YORK
Goods and/or Services:
For: Veterinary pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Veterinary pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Medicated dermatolo...